Dipna Pharmachem Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Dipna Pharmachem Ltd. on BSE

Search Inside the pdf :

Dipna Pharmachem Ltd.

13 Mar 2025

13.82

-0.14%

AGM

Dipna Pharmachem Ltd - 543594 - Notice Of Extra-Ordinary General Meeting ('EGM') Of The Company

BSE India

We hereby inform you that the Board of of the Company has decided to call Extra- Ordinary General Meeting of the Company to be held on Friday, 4th April, 2025 at 3:00 P.M through Video Conferencing("VC")/ other Audio Visual Means ("OAVM")

pdf

Dipna Pharmachem Ltd.

12 Mar 2025

13.82

-0.14%

Board Meeting

Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Wednesday, 12th March, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 03:00 P.M. and concluded at 05:00 P.M. inter-alia has: 1. Considered and approved Valuation Report issued by Mr. Manish Santosh Buchasia, Registered Valuer, Ahmedabad, in accordance with Regulation 164 of SEBI (ICDR) Regulation, 2018. 2. Decided to hold Extra-Ordinary General Meeting ('EGM') of the shareholders of the Company on Friday, 4th April, 2025 at 03:00 P.M. through Video Conferences ('VC') / Other Audio-Visual Means ('OAVM').

pdf

Dipna Pharmachem Ltd.

07 Mar 2025

13.82

-0.14%

Board Meeting

Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/03/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 12th March, 2025, at 03:00 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss, consider and approve, inter-alia: 1.The draft Valuation Report for issue of Convertible warrants on preferential basis. 2.The notice convening Extra- Ordinary General Meeting of the Company. 3.Any other agenda/ business matter to be discussed with the permission of Chairperson of the Board Meeting.

pdf

Dipna Pharmachem Ltd.

24 Feb 2025

13.82

-0.14%

Board Meeting

Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Monday, 24th February, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 04:00 P.M. and concluded at 04:30 P.M. inter-alia has, considered and approved 1. Raising of funds upto Rs. 99.99 Crores (Rupees Ninety-Nine Crores and Ninety-Nine Lakhs Only) by way of issue of Warrants (hereinafter referred to as 'Convertible Warrants'), through preferential allotment to the person(s)/ entity(ies) belonging to 'Promoter and Promoter Group Category' and 'Non-Promoter category', as per Chapter V of SEBI (ICDR) Regulations, 2018, subject to approval of Shareholders and other authorities concerned.

pdf

Dipna Pharmachem Ltd.

11 Feb 2025

13.82

-0.14%

Board Meeting

Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday, 24th February, 2025, at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. Proposal of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis. 2. Any other agenda/ business matter to be discuss with the permission of Chairperson of the Board Meeting. Kindly take the same on your record and oblige us.

pdf

Dipna Pharmachem Ltd.

06 Feb 2025

13.82

-0.14%

Board Meeting

Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Thursday, 6th February, 2025 which commenced at 03:00 P.M. and concluded at 03:20 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, Board of Directors has decided not to proceed with the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis.

pdf

Dipna Pharmachem Ltd.

30 Jan 2025

13.82

-0.14%

Board Meeting

Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday, 6th February, 2025 at 03:00 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. Proposal of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis. 2. Any other agenda/ business matter to be discuss with the permission of Chairperson of the Board Meeting.

pdf